⌘K

Home/Filings/4/A/0001213900-23-068265

4/A//SEC Filing

Shah Vinay 4/A

Accession 0001213900-23-068265

CIK 0001708331other

View on SEC.gov Company Profile

Filed

Aug 15, 8:00 PM ET

Accepted

Aug 16, 5:00 PM ET

Size

5.6 KB

Accession

0001213900-23-068265

Insider Transaction Report

Form 4/AAmended

Period: 2023-06-20

Virpax Pharmaceuticals, Inc.VRPX

Chief Financial Officer

Transactions

Award
Stock Option (right to buy)
2023-06-20+100,000→ 100,000 total
Exercise: $0.99From: 2024-06-20Exp: 2033-06-20→ Common Stock (100,000 underlying)

Footnotes (1)

[F1]25% of the shares subject to the option will vest after 12 months of continuous service, and the remaining 75% of the shares subject to the Option will vest in equal monthly installments over the next 24 months of continuous service

Documents

1 file

4
ownership.xml

Issuer

Virpax Pharmaceuticals, Inc.

CIK 0001708331

Entity typeother

Related Parties

1

filerCIK 0001753078

Filing Metadata

Form type: 4/A
Filed: Aug 15, 8:00 PM ET
Accepted: Aug 16, 5:00 PM ET
Size: 5.6 KB

View on SEC.gov